Why the strongest recovery can create the biggest cash squeeze

Growth does not usually kill manufacturers. Unfunded growth often does. 

The latest S&P UK manufacturing PMI printed 51.9 for July, down from 52.5. It was a four-month low and below the flash reading of 52.8, but it still marked a ninth consecutive month of expansion. Most commentary treated the release as solid but slowing. 

My concern is more specific: July may be the point where working capital risk starts to build, while the headline data still looks broadly positive. 

Global manufacturing remains in expansion, but July PMI data shows stock-building easing from spring peaks and input buying slowing across major economies. The UK remains one of the stronger performers. The question is whether the working capital implications are being read closely enough. 

The headline fell for reasons that look helpful on the surface. S&P pointed to a steep reduction in stocks, slower jobs growth and a sharp easing in supplier delivery times. Input cost inflation also reached a five-month low. 

The detail underneath is more uncomfortable. Output hit 52.9, the strongest reading since September 2024. New orders rose for an eighth month. Export orders rose for a seventh, across North America, the EU, China, India and South Korea. Backlogs increased for the first time since April 2022. 

Order books are filling, inventory is being drawn down and headcount is largely flat. 

That combination matters. Destocking into a rising order book can release cash in the short term, but it may also create a delayed funding requirement if demand continues. 

Since the tariff shock of spring last year, many manufacturers have held cover. They then had to absorb disruption from a cyber attack affecting the country’s largest carmaker, followed by Middle East disruption, the Houthi blockade and oil above $100 a barrel in the last week of July. Holding buffer stock was prudent, but for many mid-market businesses it was funded through invoice discounting and overdraft facilities that had already been repriced. 

That buffer is now unwinding. 

What stands out is how closely the UK picture mirrors the global data. Across major manufacturing economies, precautionary buying and stock-building have started to moderate from spring highs. That can be a sign of normalisation. It can also be the pause before the next working capital squeeze. 

Globally, the share of manufacturers buying for safety stock has fallen to a five-month low from an April peak, and input buying is growing at the slowest rate this year. The unwind releases working capital and can flatter July management accounts, but only once. 

If demand continues and inventory buffers keep falling, many manufacturers will need to restock. Raw materials go back in, WIP rises, debtor days extend and the cash conversion cycle lengthens at the point when management teams are celebrating volume growth. 

This risk is easy to underestimate, and FRP has measured the gap. In our Manufacturing Agenda research, more than 1,000 UK manufacturing decision makers, alongside 108 lenders and investors, were asked what triggers action: 

The gap is stark. Boards are often managing the risks that dominate the news agenda, while funders are watching the risk that can end the business. 

Those two lenses produce very different readings of the July release. A manufacturer may see easing delivery times and conclude that the supply chain is finally behaving after two years of stress. A lender may see stock coming off the balance sheet and ask whether that is a structural improvement or a temporary working capital release. 

This is what we at FRP increasingly think of as the decision economy. Data is abundant, but capital is not. Advantage sits with businesses that read the same numbers as everyone else and act on what those numbers imply, not just what they report. 

Many of the businesses I get called into do not fail in the trough. They fail during recovery, when growth outruns the funding available to support it. In many cases, the board was looking through the first lens while the funder was looking through the second. 

The second line in the PMI release should trouble anyone with tier three exposure. Small manufacturers reported a mild fall in production volumes in July, while medium and large manufacturers reported growth. 

That points to a recovery shaped by balance sheet capacity. Larger firms can fund cover, absorb an energy spike, hold price and ride out a disrupted quarter. Smaller suppliers often cannot. As resilience becomes a procurement issue as well as an operational one, customers have a stronger incentive to concentrate spend among fewer, better-capitalised partners. 

Timing is what turns a manageable funding requirement into a restructuring mandate. The FRP Manufacturing Agenda found that 45% of manufacturers reported difficulty securing new lending or refinancing, while more lenders expected to reduce or exit manufacturing exposure than increase it. If order growth becomes a restocking cycle, many businesses will be looking for additional working capital in a selective credit market. 

Employment is another warning sign. Staffing has barely moved for four months, while backlogs have grown for the first time in more than three years. Taking work without resourcing it can be defensible for a quarter. If it carries on, it becomes late delivery, liquidated damages and lost customer confidence. Approved supplier status is usually lost well before it is formally withdrawn. 

None of this is pessimism about the sector. Global production is running near 3%, against a long-run average closer to 2%. Demand is real and broad. Funding is not unobtainable either: restocking creates the assets that asset-based lenders advance against, and almost one in four invoice finance and ABL clients is already a manufacturer. The key is arranging funding while the numbers still look like July’s. 

This is why restructuring is increasingly about anticipation rather than intervention. By the time working capital becomes the presenting issue, the decisions that created it were often taken six to twelve months earlier. 

Three questions worth putting to the board this month, whether you run a manufacturer or lend to one: 

The distress in this cycle may not look like a collapse in demand. It may look like a business winning more work than its balance sheet can support. 

Resilience is financed.